-
1
-
-
0037673933
-
Control of osteoblast function and regulation of bone mass
-
Harada S., and Rodan G.A. Control of osteoblast function and regulation of bone mass. Nature 423 (2003) 349-355
-
(2003)
Nature
, vol.423
, pp. 349-355
-
-
Harada, S.1
Rodan, G.A.2
-
2
-
-
61449426235
-
Targeting bone morphogenetic protein antagonists: in vitro and in vivo evidence of their role in bone metabolism
-
Tsialogiannis E., Polyzois I., Oak Tang Q., Pavlou G., Tsiridis E., and Heliotis M. Targeting bone morphogenetic protein antagonists: in vitro and in vivo evidence of their role in bone metabolism. Expert Opin. Ther. Targets 13 (2009) 123-137
-
(2009)
Expert Opin. Ther. Targets
, vol.13
, pp. 123-137
-
-
Tsialogiannis, E.1
Polyzois, I.2
Oak Tang, Q.3
Pavlou, G.4
Tsiridis, E.5
Heliotis, M.6
-
3
-
-
0031608330
-
The bone morphogenetic protein family: multifunctional cellular regulators in the embryo and adult
-
Wozney J.M. The bone morphogenetic protein family: multifunctional cellular regulators in the embryo and adult. Eur. J. Oral Sci. 106 Suppl. 1 (1998) 160-166
-
(1998)
Eur. J. Oral Sci.
, vol.106
, Issue.SUPPL. 1
, pp. 160-166
-
-
Wozney, J.M.1
-
4
-
-
0242668869
-
Bone morphogenetic proteins, their antagonists, and the skeleton
-
Canalis E., Economides A.N., and Gazzerro E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr. Rev. 24 (2003) 218-235
-
(2003)
Endocr. Rev.
, vol.24
, pp. 218-235
-
-
Canalis, E.1
Economides, A.N.2
Gazzerro, E.3
-
6
-
-
58249092177
-
Bone morphogenetic protein 2 therapy for craniofacial surgery
-
Smith D.M., Cooper G.M., Mooney M.P., Marra K.G., and Losee J.E. Bone morphogenetic protein 2 therapy for craniofacial surgery. J. Craniofac. Surg. 19 (2008) 1244-1259
-
(2008)
J. Craniofac. Surg.
, vol.19
, pp. 1244-1259
-
-
Smith, D.M.1
Cooper, G.M.2
Mooney, M.P.3
Marra, K.G.4
Losee, J.E.5
-
7
-
-
51349159693
-
The use of bone morphogenetic protein in lumbar spine surgery
-
Rihn J.A., Gates C., Glassman S.D., Phillips F.M., Schwender J.D., and Albert T.J. The use of bone morphogenetic protein in lumbar spine surgery. J. Bone Joint Surg. Am. 90 (2008) 2014-2025
-
(2008)
J. Bone Joint Surg. Am.
, vol.90
, pp. 2014-2025
-
-
Rihn, J.A.1
Gates, C.2
Glassman, S.D.3
Phillips, F.M.4
Schwender, J.D.5
Albert, T.J.6
-
8
-
-
0346996450
-
Signal transduction of bone morphogenetic protein receptors
-
Nohe A., Keating E., Knaus P., and Petersen N.O. Signal transduction of bone morphogenetic protein receptors. Cell. Signal. 16 (2004) 291-299
-
(2004)
Cell. Signal.
, vol.16
, pp. 291-299
-
-
Nohe, A.1
Keating, E.2
Knaus, P.3
Petersen, N.O.4
-
9
-
-
24644482494
-
The BMP signaling and in vivo bone formation
-
Cao X., and Chen D. The BMP signaling and in vivo bone formation. Gene 357 (2005) 1-8
-
(2005)
Gene
, vol.357
, pp. 1-8
-
-
Cao, X.1
Chen, D.2
-
10
-
-
54949147176
-
New regulators of NF-kappaB in inflammation
-
Ghosh S., and Hayden M.S. New regulators of NF-kappaB in inflammation. Nat. Rev. Immunol. 8 (2008) 837-848
-
(2008)
Nat. Rev. Immunol.
, vol.8
, pp. 837-848
-
-
Ghosh, S.1
Hayden, M.S.2
-
11
-
-
14544269951
-
NF-kappaB in human disease: current inhibitors and prospects for de novo structure based design of inhibitors
-
Pande V., and Ramos M.J. NF-kappaB in human disease: current inhibitors and prospects for de novo structure based design of inhibitors. Curr. Med. Chem. 12 (2005) 357-374
-
(2005)
Curr. Med. Chem.
, vol.12
, pp. 357-374
-
-
Pande, V.1
Ramos, M.J.2
-
12
-
-
0029874138
-
The NF-kappa B and I kappa B proteins: new discoveries and insights
-
Baldwin Jr. A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14 (1996) 649-683
-
(1996)
Annu. Rev. Immunol.
, vol.14
, pp. 649-683
-
-
Baldwin Jr., A.S.1
-
13
-
-
34047173496
-
Epithelial NEMO links innate immunity to chronic intestinal inflammation
-
Nenci A., Becker C., Wullaert A., Gareus R., van Loo G., Danese S., Huth M., Nikolaev A., Neufert C., Madison B., Gumucio D., Neurath M.F., and Pasparakis M. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446 (2007) 557-561
-
(2007)
Nature
, vol.446
, pp. 557-561
-
-
Nenci, A.1
Becker, C.2
Wullaert, A.3
Gareus, R.4
van Loo, G.5
Danese, S.6
Huth, M.7
Nikolaev, A.8
Neufert, C.9
Madison, B.10
Gumucio, D.11
Neurath, M.F.12
Pasparakis, M.13
-
14
-
-
0034284715
-
Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex
-
May M.J., D'Acquisto F., Madge L.A., Glockner J., Pober J.S., and Ghosh S. Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 289 (2000) 1550-1554
-
(2000)
Science
, vol.289
, pp. 1550-1554
-
-
May, M.J.1
D'Acquisto, F.2
Madge, L.A.3
Glockner, J.4
Pober, J.S.5
Ghosh, S.6
-
15
-
-
33750358664
-
Use of cell permeable NBD peptides for suppression of inflammation
-
Strickland I., and Ghosh S. Use of cell permeable NBD peptides for suppression of inflammation. Ann. Rheum. Dis. 65 Suppl. 3 (2006) iii75-iii82
-
(2006)
Ann. Rheum. Dis.
, vol.65
, Issue.SUPPL. 3
-
-
Strickland, I.1
Ghosh, S.2
-
16
-
-
0041845297
-
E3 ubiquitin ligase Smurf1 mediates core-binding factor alpha1/Runx2 degradation and plays a specific role in osteoblast differentiation
-
Zhao M., Qiao M., Oyajobi B.O., Mundy G.R., and Chen D. E3 ubiquitin ligase Smurf1 mediates core-binding factor alpha1/Runx2 degradation and plays a specific role in osteoblast differentiation. J. Biol. Chem. 278 (2003) 27939-27944
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 27939-27944
-
-
Zhao, M.1
Qiao, M.2
Oyajobi, B.O.3
Mundy, G.R.4
Chen, D.5
-
17
-
-
4444306858
-
The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis
-
Dai S., Hirayama T., Abbas S., and Abu-Amer Y. The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis. J. Biol. Chem. 279 (2004) 37219-37222
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 37219-37222
-
-
Dai, S.1
Hirayama, T.2
Abbas, S.3
Abu-Amer, Y.4
-
18
-
-
0027946689
-
Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage
-
(published erratum appears in J Cell Biol 1995 Feb;128(4):following 713)
-
Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., Rosen V., Wozney J., Fujisawa-Sehara A., and Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 127 (1994) 1755-1766 (published erratum appears in J Cell Biol 1995 Feb;128(4):following 713)
-
(1994)
J. Cell Biol.
, vol.127
, pp. 1755-1766
-
-
Katagiri, T.1
Yamaguchi, A.2
Komaki, M.3
Abe, E.4
Takahashi, N.5
Ikeda, T.6
Rosen, V.7
Wozney, J.8
Fujisawa-Sehara, A.9
Suda, T.10
-
19
-
-
41149125432
-
Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway
-
Yamashita M., Otsuka F., Mukai T., Otani H., Inagaki K., Miyoshi T., Goto J., Yamamura M., and Makino H. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway. J. Endocrinol. 196 (2008) 601-613
-
(2008)
J. Endocrinol.
, vol.196
, pp. 601-613
-
-
Yamashita, M.1
Otsuka, F.2
Mukai, T.3
Otani, H.4
Inagaki, K.5
Miyoshi, T.6
Goto, J.7
Yamamura, M.8
Makino, H.9
-
20
-
-
40849102396
-
Cross talk between Smad transcription factors and TNF-alpha in intervertebral disc degeneration
-
Hiyama A., Mochida J., Omi H., Serigano K., and Sakai D. Cross talk between Smad transcription factors and TNF-alpha in intervertebral disc degeneration. Biochem. Biophys. Res. Commun. 369 (2008) 679-685
-
(2008)
Biochem. Biophys. Res. Commun.
, vol.369
, pp. 679-685
-
-
Hiyama, A.1
Mochida, J.2
Omi, H.3
Serigano, K.4
Sakai, D.5
-
21
-
-
34047152284
-
TNF-alpha inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling
-
Mukai T., Otsuka F., Otani H., Yamashita M., Takasugi K., Inagaki K., Yamamura M., and Makino H. TNF-alpha inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling. Biochem. Biophys. Res. Commun. 356 (2007) 1004-1010
-
(2007)
Biochem. Biophys. Res. Commun.
, vol.356
, pp. 1004-1010
-
-
Mukai, T.1
Otsuka, F.2
Otani, H.3
Yamashita, M.4
Takasugi, K.5
Inagaki, K.6
Yamamura, M.7
Makino, H.8
-
22
-
-
0033695186
-
Inhibition of osteoblast differentiation by tumor necrosis factor-alpha
-
Gilbert L., He X., Farmer P., Boden S., Kozlowski M., Rubin J., and Nanes M.S. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 141 (2000) 3956-3964
-
(2000)
Endocrinology
, vol.141
, pp. 3956-3964
-
-
Gilbert, L.1
He, X.2
Farmer, P.3
Boden, S.4
Kozlowski, M.5
Rubin, J.6
Nanes, M.S.7
-
23
-
-
34047272823
-
TNF-alpha represses transcription of human bone morphogenetic protein-4 in lung epithelial cells
-
Zhu N.L., Li C., Huang H.H., Sebald M., Londhe V.A., Heisterkamp N., Warburton D., Bellusci S., and Minoo P. TNF-alpha represses transcription of human bone morphogenetic protein-4 in lung epithelial cells. Gene 393 (2007) 70-80
-
(2007)
Gene
, vol.393
, pp. 70-80
-
-
Zhu, N.L.1
Li, C.2
Huang, H.H.3
Sebald, M.4
Londhe, V.A.5
Heisterkamp, N.6
Warburton, D.7
Bellusci, S.8
Minoo, P.9
|